Nasasbiotech is a biotechnology company that develops novel clinical solutions in liquid biopsy to improve the diagnosis, prognosis and treatment of cancer.
Nasasbiotech’s solutions are based on oncologists’ needs and follow a novel and disruptive approach.
Biomedicine developments of the Translational Medical Oncology Laboratory of the Health Research Institute of Santiago de Compostela (IDIS).
Study of circulating tumour cells, their role in the formation of metastasis, their use as tools of diagnosis and prognosis, and the development of systems for their control and capture.
Nasasbiotech is a spin off from a biomedicine research project developed at the Translational Medical Oncology Laboratory of the Health Research Institute of Santiago de Compostela (IDIS).
Its aim is to reach clinical practice and overcome the current main challenge in oncology: the process of metastasis, which is responsible for 90% of cancer-related deaths.
Focused on the process of metastasis and specially on CTCs, as they are intermediaries and responsible for the formation of metastasis.
The philosophy of this Laboratory’s research projects is to provide useful tools to solve oncologists’ main medical needs.